Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Epigenetic Approaches to Link Autoimmune Risk Variants with Distal Dysregulated Genes
EF 2025-26
Résumé
Autoimmune diseases—such as multiple sclerosis, and rheumatoid arthritis—are common amongst Canadians. They are debilitating, imposing economic burdens that cost Canadians billions of dollars annually. For most of these diseases, we do not know the exact mechanism that leads to disease. However, these diseases tend to run in families, meaning genetics is a promising window to gain insights into the process of disease progression and risk. If we can find a genetic marker and any related genes to disease, we can target them to develop therapeutics. Already, it has been proven that drugs developed with a genetic basis have a higher chance of passing efficacy tests as compared to drugs without genetic support. My study aims to discover novel genes associated with autoimmune diseases and uncover drug targets that can lead to disease treatment through integrating technologies that each reveal unique information about the genome.
Researchers have already found hundreds of genetic markers associated with risk for most autoimmune diseases. Although discovered, we fail to understand why over half of these risk variants lead to disease, i.e. we do not know what genes are implicated. If we wish to continue with current methodologies to uncover the missing genes, we must recruit thousands of people, incurring millions of dollars in research fees. My research offers an alternative, a novel way to scan the genome without prohibitive costs. We hypothesize we can develop computer algorithms to integrate the output from technologies that read how genes behave, not just their code. Through combining these technologies from published studies, we could find new genes associated with autoimmune risk to guide pharmaceutical development, and reduce the billions of dollars of economic burden.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
573337
Name
Wang William
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Epigenetic Approaches to Link Autoimmune Risk Variants with Distal Dysregulated Genes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Autoimmune Diseases; Bioinformatics; Computational Genetics; Dnase I Hypersensitive Site (Dhs) Mapping; Expression Quantitative Trait Locus (Eqtl) Mapping; Gene Regulation; Genome Wide Association Studies (Gwas); High Throughput Chromosome Conformation Capture (Hi-C); Multiple Test Correction; Trans-Eqtl Mapping
Abstract
Autoimmune diseases—such as multiple sclerosis, and rheumatoid arthritis—are common amongst Canadians. They are debilitating, imposing economic burdens that cost Canadians billions of dollars annually. For most of these diseases, we do not know the exact mechanism that leads to disease. However, these diseases tend to run in families, meaning genetics is a promising window to gain insights into the process of disease progression and risk. If we can find a genetic marker and any related genes to disease, we can target them to develop therapeutics. Already, it has been proven that drugs developed with a genetic basis have a higher chance of passing efficacy tests as compared to drugs without genetic support. My study aims to discover novel genes associated with autoimmune diseases and uncover drug targets that can lead to disease treatment through integrating technologies that each reveal unique information about the genome.
Researchers have already found hundreds of genetic markers associated with risk for most autoimmune diseases. Although discovered, we fail to understand why over half of these risk variants lead to disease, i.e. we do not know what genes are implicated. If we wish to continue with current methodologies to uncover the missing genes, we must recruit thousands of people, incurring millions of dollars in research fees. My research offers an alternative, a novel way to scan the genome without prohibitive costs. We hypothesize we can develop computer algorithms to integrate the output from technologies that read how genes behave, not just their code. Through combining these technologies from published studies, we could find new genes associated with autoimmune risk to guide pharmaceutical development, and reduce the billions of dollars of economic burden.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, William
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~